Contrave ER 8-90 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DR26FM08F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,508
Award facts
- Contract value 100% obligated
- $4,507.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,507.62 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) under a firm fixed-price contract. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing contract vehicle with the DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive award processes positions the company as a key participant in the DLA's pharmaceutical distribution network, which is expected to evolve under the planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DR26FM08F?
SPE2DR26FM08F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FM08F worth?
The government has obligated $4,508 on SPE2DR26FM08F.
Is contract SPE2DR26FM08F an order under another contract?
Yes. SPE2DR26FM08F is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM08F competed?
The extent of competition for SPE2DR26FM08F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award